TABLE 1

Liposome Pharmacokinetics

Tissue3 h4 h6 h8 h16 h24 h48 h72 h96 h
2.3  (M)1.4  (M)
Tumor1.8  (M)8  (G)2.0  (M)12  (G)18  (G)12.6  (S)10.6  (S)1.2  (M)2  (G)
9.6  (S)17  (G*)14.2  (S)24  (G*)20  (G*)21  (G)8  (G)9  (S)4  (G*)
18  (G*)13  (G*)
Liver1.2  (G)41.1  (M)17  (G)19  (G)27.5  (M)25.1  (M)23.9  (M)2  (G)
10.2  (S)14.9  (S)15.5  (S)15.1  (S)
20  (G)16  (G)
Spleen21  (G)19.6  (M)24  (G)27  (G)16  (M)10.5  (M)10.7  (M)8  (G)
15.9  (S)34.5  (S)34.2  (S)35.5  (S)
26  (G)24  (G)
Kidneys2.2  (M)3.74  (M)3.1  (M)2.9  (M)
4.7  (S)5.9  (S)4.9  (S)5  (S)
Lungs1.8  (M)2  (M)1.4  (M)1.5  (M)
4.5  (S)2.5  (S)1.6  (S)1.2  (S)
Red marrow0.5  (M)22.3  (G)0.4  (M)17.3  (G)9.3  (G)0.03  (M)0.01  (M)9×10−4  (M)0.13  (G)
8.2  (S)5.1  (S)0.6  (S)0.04  (S)2×10−3  (S)
9  (G)1.8  (G)
  • * In liver tumor.

  • M = MLV; S = SUV; G = GM1.

  • Data are percentage injected dose per gram of tissue.